Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical GuidelinesCOVID-19 감염 예방 및 치료를 위한 Ivermectin: 임상 지침을 제공하기 위한 체계적인 검토, 메타 분석 및 시험 순차 분석Meta-Analysis Published on 2021-06-212022-09-11 Journal: American journal of therapeutics [Category] SARS, 치료제, [키워드] 95% confidence interval adverse event Analysis anti-inflammatory properties antiparasitic Antiviral approach Area average average risk benefit certainty Chemoprophylaxis clinical Clinical course clinical trials conducted COVID-19 COVID-19 infection database death Deterioration Efficacy estimate Evidence evidence of guideline high risk Inclusion Ivermectin ivermectin treatment less mechanical ventilation Medicine meta-analyses Meta-analysis Mortality no difference outcome pandemic participant prevention Prophylaxis provided Randomized controlled trial reduce reduced reduced risk reducing mortality reductions in review Risk of bias risk ratio robust SARS-CoV-2 pandemic SARS-CoV-2 virus searched secondary secondary outcome Secondary outcomes sequential analysis severe adverse events severe disease suggested tested the SARS-CoV-2 the SARS-CoV-2 virus treatment trial treatment trials Trial trial sequential analyses trial sequential analysis [DOI] 10.1097/MJT.0000000000001402 PMC 바로가기 [Article Type] Meta-Analysis
Quality of and Recommendations for Relevant Clinical Practice Guidelines for COVID-19 Management: A Systematic Review and Critical AppraisalMedicine Published on 2021-06-102022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] AGREE II analyzed antiviral drug applicability appraisal Chemoprophylaxis clinical Clinical practice conducted coronavirus disease COVID-19 criteria data extraction database Diagnosis discharge discharge management domain eligible evaluate forms greater guideline Health status Hydroxychloroquine information interquartile range IQR Isolation majority management median Methodological quality morbidity and mortality patients patients with COVID-19 Practice Prophylaxis Quality R version 3.6.0 recommendation recommendations Remdesivir Repository required review SARS-CoV 2 SARS-CoV-2 severe COVID-19 significantly similarity treat treatments Trial Vaccine was used Web of Science [DOI] 10.3389/fmed.2021.630765 PMC 바로가기 [Article Type] Medicine
Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations전염병에 대한 화학 예방 실험 설계: COVID-19 연구 등록에 대한 체계적인 검토에서 얻은 통찰력Review Published on 2021-05-292022-09-10 Journal: Trials [Category] SARS, 변종, 치료기술, 치료제, [키워드] adaptive adaptive design Adaptive platform trial Adults alignment Analysis attack rate attack rates Care Chain Reaction Chemoprophylaxis Chloroquine clinically collaboration component control group coronavirus country COVID-19 COVID-19 vaccines database detect effect size effective Efficacy Efficacy and safety eligibility enrolment Epidemic Epidemics epidemiologically Evidence evidence of exit feasible feature focus followed by General population generate healthcare worker Healthcare workers Hydroxychloroquine implementation Infection Infectious disease Infectious diseases information International IQR less Long-term care Lopinavir Lopinavir/ritonavir mechanism median median size novel vaccines offer Older older adult Older adults pandemic patients polymerase chain reaction Polymerase chain reaction testing PrEP Primary outcome Prophylaxis protocol provided public health randomised Rapid recruitment Registered Repurposed drug Repurposed drugs required Result review Ritonavir robust safety analysis SARS-CoV-2 screened searched Serological testing study population supplementary material Supporting systematic review target population Trial trial infrastructure Trial registration trials utility Vaccine Vaccines virus variants was used were assessed widespread without symptom [DOI] 10.1186/s13063-021-05323-4 PMC 바로가기 [Article Type] Review
Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trialRandomized Controlled Trial Published on 2021-05-012022-10-05 Journal: International Journal of Infectious Diseases [Category] 임상, [키워드] age assigned Asymptomatic baseline Chemoprophylaxis Cluster Combination Complete confidence interval coronavirus disease COVID-19 defined Evidence examined healthy highest Hydroxychloroquine interruption Ivermectin Laboratory men Open-label participant positive positive PCR test povidone-iodine primary analysis Primary outcome Prophylaxis Randomized controlled trial randomized trial Randomly receive reduce reducing regimen risk reduction SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection seronegative shown Side effect Singapore Spread statistically significant difference Vitamin Vitamin C was performed Zinc [DOI] 10.1016/j.ijid.2021.04.035 PMC 바로가기 [Article Type] Randomized Controlled Trial
Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial확인된 COVID-19 사례(CORIPREV)의 긴밀한 접촉에서 SARS-CoV-2에 대한 노출 후 예방: 클러스터 무작위 시험을 위한 연구 프로토콜Study Protocol Published on 2021-03-222022-09-10 Journal: Trials [Category] SARS, 임상, 치료기술, 치료제, [키워드] 1:1 adaptive Analysis approach attack rate baseline Chain Reaction Chemoprophylaxis close contact Cluster Cluster randomization Clusters Combination confirmed COVID-19 case Confirmed COVID-19 infection Contact control arm correlation coefficient Course COVID-19 COVID-19 infection COVID-19 pandemic defined detect Diseases drug early treatment Efficacy epidemiological estimate evaluate excluded exposure to generalized linear mixed model Hospitalization ICC include incorporation individual Infection Infectious diseases Interim analyses interim analysis Intervention intervention arm life linear mixed model logit Lopinavir Lopinavir/ritonavir medication microbiologically modify Mortality multicenter novel Open-label oral lopinavir/ritonavir outcome participant polymerase chain polymerase chain reaction positive Post-exposure prophylaxis Prevent prevention prevention approach primary analysis Primary outcome Probability Prophylaxis protocol psychological Impact Quality of life Randomized controlled trial Registered Relative risk respiratory Respiratory failure respiratory tract risk reduction Ritonavir Safe Sample size sample size calculation SARS-CoV-2 secondary secondary attack rate Secondary outcomes Seropositivity specimen Study protocol study visit subset supplementary material Support switching symptomatic symptomatic COVID-19 Trial Trial registration ventilator [DOI] 10.1186/s13063-021-05134-7 PMC 바로가기 [Article Type] Study Protocol
Prevention of Covid-19 Infection and Related Complications by Ozonized OilsArticle Published on 2021-03-222022-10-30 Journal: Journal of Personalized Medicine [Category] COVID-19, [키워드] Administered administration Antiviral cancer patient Cell cells Chemoprophylaxis Combination Complication complications COVID-19 COVID-19 challenge test COVID-19 infection COVID-19 pandemic COVID-19 patient develop Efficacy eight evaluated expected expired gas feasibility healthy subject High dose high risk hydrogen peroxide In vitro studies in vivo incidence increase incubated indicate infected patients Infection Infection prevention Intervention less Level lung neutralize Oil Oropharyngeal oxidative stress oxygen penetrate per day Prevent prevention protocol qPCR quantitative PCR SARS-CoV-2 Standard dose subjects therapeutic purpose Treatment virus load was tested [DOI] 10.3390/jpm11030226 PMC 바로가기 [Article Type] Article
Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control studyResearch Article Published on 2021-02-162022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, [키워드] 95% CI age Analysis AOR association Case-control case-control study Chemoprophylaxis conducted Control COVID COVID-19 Data collection defined Diagnosis dose drug exposure Factor Gender healthcare healthcare worker Hydroxychloroquine India involved Ivermectin logistic regression model pandemic physical activity positive profession Prophylaxis reduction Result role RT-PCR SARS-COV-2 infection Stata tested therapeutic Type was done was performed were used [DOI] 10.1371/journal.pone.0247163 PMC 바로가기 [Article Type] Research Article
Practical Guide for the Prescription of Malaria Chemoprophylaxis for the Primary Care Physicianarticle Published on 2020-12-312024-09-01 Journal: P R Health Sci J [Category] 말라리아, [키워드] Chemoprophylaxis guide malaria prevention Prophylaxis [Article Type] article
Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological ReviewPharmacology Published on 2020-12-172022-10-31 Journal: Frontiers in Pharmacology [Category] COVID-19, [키워드] affecting agent airway epithelial cells Analysis animal model Asymptomatic carrier candidate drug Chemoprophylaxis clinical trial Concentration coronavirus coronavirus disease 19 COVID-19 COVID-19 pandemic dissect dose Efficacy Endolysosomes Evidence Factor HCQ HCW healthcare high-risk population Hydroxychloroquine in vivo inhibit inhibitory effect observational study pharmacokinetic pharmacological Postexposure Prophylaxis presymptomatic transmission Prophylactic Prophylaxis PROTECT replicate responsible reveal review SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 TMPRSS2 Transmissibility Transport Vero Cell viral entry [DOI] 10.3389/fphar.2020.593099 PMC 바로가기 [Article Type] Pharmacology
Venous Thromboembolism in COVID-19COVID-19의 정맥 혈전색전증Review Published on 2020-12-012022-09-11 Journal: Thrombosis and haemostasis [Category] MERS, SARS, 바이오마커, [키워드] Biomarkers Characteristics Chemoprophylaxis coronavirus disease Coronavirus disease 2019 COVID-19 dose Evidence flu general treatment Guidance H1N1 hematological ill patient mechanism pandemic Pathogenesis patients with COVID-19 Prophylaxis Pulmonary embolism recommendation risk Risk assessment risk factor swine flu Thromboinflammation Treatment Venous Thromboembolism VTE [DOI] 10.1055/s-0040-1718532 PMC 바로가기 [Article Type] Review